- Network: HULU
- Series Premiere Date: Mar 3, 2022
Critic Reviews
- Critic score
- Publication
- By date
-
"The Dropout" will be tough to top, or even match, because of the way Seyfried, along with Meriwether and her writers, marry the visible facets of Holmes' put-on with her skewed ethical paradigm. ... ["The Dropout" makes] a person appreciate the scope of crime – and, better still, the extraordinary pleasure of watching Seyfried and the rest of the actors recreate this case with genuine confidence.
-
Think, “The Social Network” if it were less clinical, more emotionally perceptive, and somehow even sometimes sympathetic towards its similarly strange, dissocial, and pathological protagonist. It’s also led by an outstanding performance by Amanda Seyfried.
-
You get a sense of who Holmes was, what drove her ambition and, ultimately, the desperation behind her foolish delusion that she had to stay the course, even as things careened out of control. Yet the series never lionizes her or glorifies her actions—tempting given the scale and implausibility of what she pulled off for as long as she did. ... [The Dropout] gives us something much more valuable, something that Theranos hoped to achieve itself: A new, better way of doing things.
-
Hulu’s portrayal of her girlbossing too close to the sun is captivating through and through.
-
The artistry of “The Dropout” is that while it never makes excuses for Holmes and shines a harsh spotlight on her bizarre behavior and sociopathic-level lack of empathy, we see her as a three-dimensional human being who had unlimited potential and probably WOULD have achieved something great had she listened to those who were trying to get her to slow down and do things the right way.
-
Start engraving a Best Actress Emmy for Amanda Seyfried who is sensational as Theranos founder and fraudster Elizabeth Holmes in a true-crime story that is more than compulsively watchable, it’s a cautionary fable that really stings.
-
The discovery that Elizabeth might not be the most interesting or important person on screen at all times is what makes The Dropout so watchable and so often startlingly moving.
-
Great cast, fine performances, consistently entertaining.
-
Compelling. ... Amanda Seyfried humanizes this enigmatic faux visionary by capturing her eerie intensity and drive. [14 - 27 Mar 2022, p.6]
-
This textured and tenacious show is much more than a villain’s story, and showcases Seyfried’s talents at an exciting phase in her career.
-
Employing a deftly selected soundtrack of early-to-mid-aughts bangers to bring home the cultural specificity of her rise and fall, the limited series compounds both the gravity and ridiculousness of what Holmes did not achieve. Seyfried finds Holmes’s awkward, serious, entrepreneurship-driven persona not only in her verbal oddities, but also in her physicality. ... The interpretation is as important as the details of Holmes’s story.
-
The Dropout succeeds because of Seyfried’s work as Holmes, but it’s also a messier portrait of Holmes’s youth, one that leads to a much more nuanced and multifaceted image of her by the time Theranos is in full swing.
-
Boasting an inordinately good cast in even relatively minor roles, the series adopts an unexpectedly sympathetic posture toward Holmes, at least in the early going, as she seized on the idea of improving the blood-testing process before dropping out of Stanford to pursue her vision.
-
Seyfried, who was Oscar-nominated for "Mank" last year, is just as revelatory here, but strictly as an actress, not as a window into the phenomenon of Holmes. The portrayal is absorbing, committed and morbidly fascinating. ... Whether Holmes was an enchantress remains mysterious, though she certainly represents the kind of millennial con artistry that's in vogue right now.
-
The show succeeds where it counts—and where just about every other recent series in its lane fails: in creating a character specific and detailed enough in her weirdness to say something new about the real woman.
-
Sure, there’s nothing here you couldn’t have gotten from the two-hour Gibney documentary. But the Gibney documentary doesn’t have an award-worthy performance from Seyfried, and it doesn’t have the pleasures of these little acting victories from Metcalf, from Smith, from Kate Burton, from Michael Ironside, from Elizabeth Marvel, from Michaela Watkins. And more.
-
The Dropout slowly draws you in, because the stakes are so much higher and Holmes’s rise is enthralling.
-
“The Dropout” succeeds where “Inventing Anna” doesn’t, creating a sharp portrait of an unnerving woman that doesn’t excuse her actions, but makes them at least more understandable (as in more easily understood, not more “relatable”).
-
It’s a maddening, gripping, and at times startlingly funny recreation of a story that would feel too absurd to be true if we didn’t already know otherwise.
-
Of course, a story this salacious and juicy was going to get the prestige miniseries treatment. And the good news is, even if it never develops into a more intriguing whole, The Dropout is made of up enough solid components — whether it’s the early trials and tribulations of the well-meaning lab workers or the corporate-thriller turn that the story eventually takes — that anyone watching should be able to find something that appeals to them.
-
The good news is that, either way, this is a tale that even in its most straightforward telling still has plenty to latch on to.
-
To some degree The Dropout is just a re-enactment of the public record — re-enactments of Elizabeth’s court deposition do a lot of the series’ expositional heavy lifting — but there is something strangely compelling about watching an actor portraying the purveyor of this audacious corporate fraud.
-
We’re going to stick with The Dropout because of Seyfried’s pitch-perfect performance as Holmes as well as the myriad guest actor performances that are already looking promising by the end of the first episode. We just hope that the show doesn’t continue to make Holmes the hero of her own story.
Awards & Rankings
User score distribution:
-
Positive: 13 out of 16
-
Mixed: 3 out of 16
-
Negative: 0 out of 16
-
Mar 9, 2022
-
Apr 15, 2022
-
Mar 22, 2022